November 18, 2026
Health news, explained with evidence
LIVE

Study Examines Norepinephrine Filtration During Specialized Liver Cancer Treatment

❤️ Conditions & Care 2 min read 👁 3

Researchers at University Hospital Leipzig investigated how extracorporeal chemofiltration affects norepinephrine levels during a specialized liver-directed chemotherapy procedure.

❤️Conditions & Care

Key points

  • Researchers studied ten CS-PHP procedures across eight patients at University Hospital Leipzig.
  • The extracorporeal chemofilter reduced circulating norepinephrine levels by over 90%.
  • Norepinephrine infusion rates surged immediately following filter activation.

A prospective observational study conducted by researchers at University Hospital Leipzig and partner institutions has looked into the dynamics of norepinephrine filtration during chemosaturation with percutaneous hepatic perfusion (CS-PHP) using melphalan. The procedure, commonly utilized for specific liver malignancies, frequently triggers profound drops in blood pressure that require high-dose vasopressor support. To explore this physiological response, the team evaluated ten procedures across eight patients, quantifying circulating norepinephrine concentrations using liquid chromatography-tandem mass spectrometry at predefined timepoints.

The investigation found that the extracorporeal filter effectively reduced circulating norepinephrine concentrations, achieving a median reduction of 91.9% during melphalan perfusion and 91.3% following bypass closure. However, despite this high filtration rate, infusion requirements for norepinephrine rose markedly from a median of 0.2 micrograms per kilogram per minute to 0.6 micrograms per kilogram per minute immediately after filter activation. These requirements stayed elevated throughout the filtration phase before dropping once the procedure concluded. Investigators note that this is an observational study with a very small sample size, meaning the findings only suggest an association between filter-based clearance and hemodynamic adjustments rather than proving direct causation.

What to know: While the study provides new physiological insights into how specialized liver perfusion therapies interact with vital blood pressure medications, it remains early-stage research. Patients considering specialized oncological treatments should always consult their healthcare providers for personalized medical advice and guidance regarding potential procedural side effects.

Source Nature Health Sciences — nature.com/articles/s41598-026-81132-6 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.